The PPAR<i>γ</i>Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects

Galina S. Bogatkevich(Medical University of South Carolina), Richard M. Silver(Medical University of South Carolina)
Pulmonary Medicine
November 1, 2011
Cited by 20


Related Papers

No related papers found

Powered by citation graph analysis